The action of the NK1 tachykinin receptor antagonist, CP 99,994, in antagonizing the acute and delayed emesis induced by cisplatin in the ferret

British Journal of Pharmacology

Volumn 119, Issue 5, 1996, Pages 931-936

  Rudd, J A ^b   Jordan, C C ^c   Naylor, R J ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Acute and delayed emesis in ferret; Cisplatin; CP 99,994; Receptor antagonist

Indexed keywords

3 (2 METHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; ANTIEMETIC AGENT; CISPLATIN; NEUROKININ 1 RECEPTOR ANTAGONIST; ONDANSETRON; 3-(2-METHOXYBENZYLAMINO)-2-PHENYLPIPERIDINE; ANTINEOPLASTIC AGENT; DRUG VEHICLE; NEUROKININ 1 RECEPTOR; PIPERIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANTIEMETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; FERRET; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; VOMITING; ANIMAL; DRUG ANTAGONISM; VEHICLES;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; FERRETS; MALE; ONDANSETRON; PIPERIDINES; RECEPTORS, NEUROKININ-1; VEHICLES; VOMITING;

EID: 0029658238     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15761.x     Document Type: Article

References (22)

1. 1 receptor antagonist, Br. J. Pharmacol., 116, 3149-3157.
2. 1 receptor antagonist, CP-99,994, in ferrets. Eur. J. Pharmacol., 249, R3-R4.
3. CUBEDDU, L.X. & HOFFMANN, I.S. (1993). Participation of serotonin on early and delayed emesis induced by initial and subsequent cyclies of cisplatinum-based chemotherapy - effects of antiemetics. J. Clin. Pharmacol., 33, 691-697.
4. BEDDU, L.X., HOFFMANN, I.S., FUENMAYOR, N.T. & FINN, A.L. (1990). Efficacy of ondansetron (GR38032F) and the role of serotonin in cisplatin-induced nausea and vomiting. New Engl. J. Med., 322, 810-816.
5. 1 receptor antagonists is mediated centrally in the ferret. Br. J. Pharmacol., 112, 516P.
6. 1 receptor antagonist GR203040. Br. J. Pharmacol., 116, 3158-3163.
7. GRUNBERG, S.M. (1993). Potential for combination therapy with the new antiserotonergic agents. Eur. J. Cancer, 29A S39-S41.
8. McLEAN, S., GANONG, A., SEYMOUR, P.A., SNIDER, R.M., DESAI, M.C., ROSEN, T., BRYCE, D.K., LONGO, K.P., REYNOLDS, L.S., ROBINSON, G., SCHMIDT, A.W., SIOK, C. & HEYM, J. (1993). Pharmacology of CP-99,994: a non-peptide antagonist of the tachykinin NK-1 receptor. J. Pharmacol. Exp. Ther., 267, 472-479.
9. RATH, U., UPADHYAYA, B.K., ARECHAVALA, E., BOCKMANN, H., DEARNALEY, D., DROZ, J.P., FOSSA, S.D., HENRIKSSON, R., AULITZKY, W.E., JONES, W.G., WEISSBACH, L., PASKA, W. & FREEMAN, A. (1993). Role of ondansetron plus dexamethasone in fractionated chemotherapy. Oncology, 50, 168-172.
10. ROILA, F. (1993). Ondansetron plus dexamethasone compared to the 'Standard' metoclopramide combination. Oncology, 50, 163-167.
11. RUDD, J.A., BUNCE, K.T. & NAYLOR, R.J. (1996). The interaction of dexamethasone with ondansetron on drug-induced emesis in the ferret. Neuropharmacology, 35, 91-97.
12. RUDD, J. A., JORDAN, C.C. & NAYLOR, R.J. (1994). Profiles of emetic action of cisplatin in the ferret: a potential model of acute and delayed emesis. Eur. J. Pharmacol., 262, R1-R2.
13. 3 receptor antagonists on models of acute and delayed emesis induced by cisplatin in the ferret. Eur. J. Pharmacol., 262, R1-R2.
14. RUDD, J.A. & NAYLOR, R.J. (1996). An interaction of ondansetron and dexamethasone antagonizing cisplatin-induced acute and delayed emesis in the ferret. Br. J. Pharmacol., 118, 209-214.
15. SANGER, G.S. & ANDREWS, P.L.R. (1993). Afterword: Unresolved issues and future prospects. In Emesis in Anti-Cancer Therapy Mechanisms and Treatment. ed. Andrews, P.L.R. & Sanger, G.S. pp. 247-249. London: Chapman & Hall Medical.
16. 1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret. Eur. J. Pharmacol., 250, R5-R6.
17. 1 receptor antagonist CP-99,994. Neuropharmacology, 33, 259-260.
18. 1) receptor antagonist CP-99,994. Neuropharmacology, 34, 1697-1699.
19. 1 receptor antagonists and the role of endogenous mediators. Br. J. Pharmacol., 114, 1343-1350.
20. 1 receptor. Br. J. Pharmacol., 115, 84-94.
21. WATSON, J.W., NAGAHISA, A., LUCOT, J.B. & ANDREWS, P.L R. (1995b). The tachykinins and emesis: towards complete control? In Serotonin and the Scientific Basis of Anti-Emetic Therapy. ed. Reynolds, D.J.M., Andrews, P.L.R. & Davis, C.J. pp. 233-238. Oxford: Oxford Clinical Communications.
22. WILDER-SMITH, O.H.G., BORGEAT, A., CHAPPUIS, P., FATHI, M. & FORNI, M. (1993). Urinary serotonin metabolite excretion during cisplatin chemotherapy. Cancer, 72, 2239-2241.